DEUTSCHE BANK AG\ - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q2 2021$98,000
-26.9%
54,008
-20.2%
0.00%
Q1 2021$134,000
+91.4%
67,713
+22.3%
0.00%
Q4 2020$70,000
-2.8%
55,352
+37.3%
0.00%
Q3 2020$72,000
-74.3%
40,307
+20.8%
0.00%
Q2 2020$280,000
+129.5%
33,374
+43.1%
0.00%
Q1 2020$122,000
+4.3%
23,317
+8.7%
0.00%
Q4 2019$117,000
+44.4%
21,443
+28.5%
0.00%
Q3 2019$81,000
-38.6%
16,691
-13.7%
0.00%
Q2 2019$132,000
-70.7%
19,346
-70.3%
0.00%
Q1 2019$451,000
+29.6%
65,141
+9.1%
0.00%
Q4 2018$348,000
-83.4%
59,701
-78.5%
0.00%
-100.0%
Q3 2018$2,096,000
-13.3%
277,754
-42.0%
0.00%0.0%
Q2 2018$2,418,000
+457.1%
478,934
+570.5%
0.00%
Q1 2018$434,000
-46.7%
71,432
-37.8%
0.00%
-100.0%
Q4 2017$814,000
+52.1%
114,842
+53.0%
0.00%
Q3 2017$535,000
-43.8%
75,072
-50.4%
0.00%
-100.0%
Q2 2017$952,000
+15.4%
151,361
+51.2%
0.00%0.0%
Q1 2017$825,000
-2.4%
100,100
+0.1%
0.00%0.0%
Q4 2016$845,000
+316.3%
100,000
+233.3%
0.00%
Q3 2016$203,00030,0000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders